5 pharmaceutical and veterinary preparations, namely, T-cell engaging biologics or drug conjugates based on biologics for therapy, biologics for immunoimaging, immunotherapy; pharmaceutical and veterinary preparations, namely, antibodies, antibody fragments, peptides or small molecules for immunotherapy treatment; pharmaceutical and veterinary nanoparticles, namely, polymers, liposomes, or antibodies modified with a chemical tag or a radiolabeled chemical tag, for nuclear imaging or therapy; pharmaceutical preparations for treatment or prevention of cancer, autoimmune or infectious disease; pharmaceutical and chemical preparations for medical purposes, namely, chemical probes or chemical tags conjugated to biologics for the treatment of cancer, autoimmune disease, or infectious disease; sanitary preparations for medical purposes; biopharmaceutical preparations for use in human and veterinary medicine for treatment of cancer, autoimmune diseases and infectious diseases; diagnostic preparations for medical purposes; chemical reagents for medical and veterinary purposes; chemicals and biological substances for medical use, namely, diagnostic reagents; pharmaceutical and veterinary preparations, namely, immune cell engaging biologics, preparations for imaging, prodrugs, or drug conjugates based on biologics for therapy, biologics, peptides or small molecules for radiotherapy, immunotherapy or chemotherapy; pharmaceutical and veterinary nanoparticles, namely, polymers, liposomes, biologics, peptides, or small molecules modified with a chemical tag or linker or a radiolabelled chemical tag, for nuclear imaging or therapy; pharmaceutical and chemical preparations for medical purposes, namely, chemical probes or chemical tags or linkers conjugated to biologics for the treatment of cancer, autoimmune disease, or infectious disease